Cancer drug glivec

Articles Galleries Videos
  • Swiss drug maker Novartis, Nexavar drug, cancer ruling benefits cheap drugs in india experts, Cancer drug glivec

    Cancer ruling benefits cheap drugs in India: Experts 15 March 2012

    A provision of the Indian Patents Act allows for a compulsory license to be awarded after three years of the grant of patent on drugs that are deemed to be too costly. Other patent rulings are imminent. A long-running case...

    Keywords: Swiss drug maker Novartis, Swiss drug maker Novartis, Swiss drug maker Novartis, Nexavar drug

    Read More